Review




Structured Review

Biometrics Ltd emg pre-amplifier
Emg Pre Amplifier, supplied by Biometrics Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/emg+pre-amplifier/pm37914560-72-1-6?v=Biometrics+Ltd
Average 90 stars, based on 1 article reviews
emg pre-amplifier - by Bioz Stars, 2026-07
90/100 stars

Images



Similar Products

97
Delsys Inc surface wireless pre amplified emg sensors
Surface Wireless Pre Amplified Emg Sensors, supplied by Delsys Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/emg+pre-amplifier/pm34175684-97-29-38?v=Delsys+Inc
Average 97 stars, based on 1 article reviews
surface wireless pre amplified emg sensors - by Bioz Stars, 2026-07
97/100 stars
  Buy from Supplier

90
Pinnacle Technology Inc eeg/emg pre-amplifier and filter model 8202
Eeg/Emg Pre Amplifier And Filter Model 8202, supplied by Pinnacle Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/emg+pre-amplifier/us12280038-435-6-8?v=Pinnacle+Technology+Inc
Average 90 stars, based on 1 article reviews
eeg/emg pre-amplifier and filter model 8202 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Cometa Srl Monteriggioni wireless, pre-amplified, bipolar electrodes with electrode spacing cometa pico emg
Wireless, Pre Amplified, Bipolar Electrodes With Electrode Spacing Cometa Pico Emg, supplied by Cometa Srl Monteriggioni, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/emg+pre-amplifier/pm40153271-50-0-12?v=Cometa+Srl+Monteriggioni
Average 90 stars, based on 1 article reviews
wireless, pre-amplified, bipolar electrodes with electrode spacing cometa pico emg - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Motion Lab Systems Inc ma-311 emg pre-amplifiers
Ma 311 Emg Pre Amplifiers, supplied by Motion Lab Systems Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/emg+pre-amplifier/us12138008-2284-3-7?v=Motion+Lab+Systems+Inc
Average 90 stars, based on 1 article reviews
ma-311 emg pre-amplifiers - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Biometrics Ltd emg pre-amplifier
Emg Pre Amplifier, supplied by Biometrics Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/emg+pre-amplifier/pm37914560-72-1-6?v=Biometrics+Ltd
Average 90 stars, based on 1 article reviews
emg pre-amplifier - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Digitimer North America LLC emg data pre-amplifier
Emg Data Pre Amplifier, supplied by Digitimer North America LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/emg+pre-amplifier/pm37516287-53-0-6?v=Digitimer+North+America+LLC
Average 90 stars, based on 1 article reviews
emg data pre-amplifier - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Cambridge Electronic Design emg pre-amplifier 1902 mk iv
Emg Pre Amplifier 1902 Mk Iv, supplied by Cambridge Electronic Design, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/emg+pre-amplifier/pmc09172156-77-0-7?v=Cambridge+Electronic+Design
Average 90 stars, based on 1 article reviews
emg pre-amplifier 1902 mk iv - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Pinnacle Technology Inc two eeg channel, two emg channel mouse pre-amplifier
Ablation of Sox14 + IGL/LGv neurons causes delayed vigilance state transitions at circadian light changes. A , B , <t>spectrograms,</t> <t>EEG/EMG</t> traces, and hypnograms over a one-hour period from a representative control mouse and an ablated mouse. C , over a 24-hour period control and Sox14 + IGL/LGv-ablated mice spend a similar percentage of time in Wake (48.24 % ± 1.96 % vs 48.22 % ± 1.71 %, p = 0.99), NREM (46.73 % ± 1.80 % vs 46.38 % ± 1.71 %, p = 0.89) and REM (5.03 % ± 0.20 % vs 5.39 % ± 0.17 %, p = 0.2). Values are mean ± s.e.m., t-test. D , E , distribution of Wake, NREM and REM in the two hours preceding and following each light transition. Light and dark hours are shaded in yellow and grey, respectively (see for comprehensive statistics). F , pairwise comparison in the content of Wake, NREM and REM between the hour preceding and each of the two hours following the light to dark transition. Control group: Wake -1 : 33.17 % ± 2.98 %, Wake 1 : 80.26 % ± 3.49 %, p < 0.0001, Wake 2 : 72.61 % ± 7.76 %, p = 0.001; NREM -1 : 60.08 % ± 2.65 %, NREM 1 : 18.39 % ± 3.29 %, p = 0.0001, NREM 2 : 25.17 % ± 7.04 %, p = 0.0015; REM -1 : 6.75 % ± 0.52 %, REM 1 : 1.35 % ± 0.45 % p = 0.0004, REM 2 : 2.18% ± 0.85 % p = 0.007. Ablated group: Wake -1 36.57 % ± 5.34 %, Wake 1 : 56.67 % ± 3.49 %, p = 0.093, Wake 2 : 75.23 % ± 7.24 %, p = 0.008; NREM -1 56.35 % ± 4.73 %, NREM 1 : 38.19 % ± 7.68 %, p = 0.093, NREM 2 : 22.36 % ± 6.64 %, p = 0.0081; REM -1 : 7.08 % ± 0.78 %, REM 1 : 5.10 % ± 1.16 %, p = 0.296, REM 2 : 2.41 % ± 0.90 %, p = 0.031. Values are mean ± s.e.m., t-test except Control REM -1 versus REM 2 , Ablated REM -1 versus REM 1 and REM 2 Wilcoxon test. G , pairwise comparison in the content of Wake, NREM and REM between the hour preceding and each of the two hours following the dark to light transition. Control group: Wake -1 : 94.77 % ± 3.48 %, Wake 1 : 63.47 % ± 9.42 %, p = 0.015, Wake 2 : 36.11 % ± 9.72 %, p = 0.015; NREM -1 : 5.22 % ± 3.48 %, NREM 1 : 34.87 % ± 8.82 % p = 0.015, NREM 2 : 57.51 % ± 8.86 % p = 0.015; REM -1 : 0.00 % ± 0.00 %, REM 1 : 1.66 % ± 0.64 %, p = 0.125, REM 2 : 6.37 % ± 1.09 %, p = 0.015. Ablated group: Wake -1 79.18 % ± 7.51 %, Wake 1 : 82.47 % ± 7.80 %, p = 0.812, Wake 2 : 39.37 % ± 8.09 %, p = 0.017; NREM -1 20.50 % ± 7.34 %, NREM 1 : 17.25 % ± 7.65 %, p = 0.848, NREM 2 : 56.31 % ± 7.22 %, p = 0.021; REM -1 : 0.31 % ± 0.21 %, REM 1 : 0.27 % ± 0.20 %, p > 0.999, REM 2 : 4.31 % ± 1.34 %, p = 0.0313. Values are mean ± s.e.m., Wilcoxon test except Ablated Wake -1 versus Wake 2 and NREM -1 versus NREM 2 t-test. H , fold change in distance travelled in the light phase (12 hours). Total distance in the dark phase (12 hours) was set at 1. Control group: 1.0 ± 0.14 (dark) versus 0.77 ± 0.26 (light); Ablated group: 1.0 ± 0.17 (dark) versus 0.52 ± 0.82 (light). I , Example trajectories for one control and one ablated mouse in the hour preceding and following the light change. Oval: ROI used for automated tracking; yellow: light, grey: dark. Histograms report the fold change in distance travelled in the hour preceding and following the light change. For the light to dark transition distance in the light was set at 1: Control group 1.0 ± 0.21 (light) 5.59 ± 1.36 (dark), p = 0.0078; Ablated group 1.0 ± 0.17 (light) 2.80 ± 0.68 (dark), p = 0.044. J , For the dark to light transition distance in the dark was set at 1: Control group 1.0 ± 0.15 vs 0.64 ± 0.31, p = 0.148; Ablated group 1.0 ± 0.28 vs 0.92 ± 0.29, p = 0.468. Values are mean ± s.e.m., Wilcoxon test except for Ablated light to dark transition t-test. A summary of statistical tests is available in .
Two Eeg Channel, Two Emg Channel Mouse Pre Amplifier, supplied by Pinnacle Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/emg+pre-amplifier/bio_rxiv__2022__02__24__481804-365-19-26?v=Pinnacle+Technology+Inc
Average 90 stars, based on 1 article reviews
two eeg channel, two emg channel mouse pre-amplifier - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Motion Lab Systems Inc bipolar electromyography (emg) pre-amplifier y03
Representative raw <t>EMG</t> data of two participants demonstrating the cortical silent period (cSP) waterfall plot collected before (Pre) and after (Post) a single session of 1 Hz rTMS delivered to the laryngeal motor cortex. Each plot shows all 30 trials from one participant for each group before and after rTMS. AdLD adductor laryngeal dystonia, EMG <t>electromyography,</t> MEP motor-evoked potential
Bipolar Electromyography (Emg) Pre Amplifier Y03, supplied by Motion Lab Systems Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/emg+pre-amplifier/pmc08858301-104-8-12?v=Motion+Lab+Systems+Inc
Average 90 stars, based on 1 article reviews
bipolar electromyography (emg) pre-amplifier y03 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


Ablation of Sox14 + IGL/LGv neurons causes delayed vigilance state transitions at circadian light changes. A , B , spectrograms, EEG/EMG traces, and hypnograms over a one-hour period from a representative control mouse and an ablated mouse. C , over a 24-hour period control and Sox14 + IGL/LGv-ablated mice spend a similar percentage of time in Wake (48.24 % ± 1.96 % vs 48.22 % ± 1.71 %, p = 0.99), NREM (46.73 % ± 1.80 % vs 46.38 % ± 1.71 %, p = 0.89) and REM (5.03 % ± 0.20 % vs 5.39 % ± 0.17 %, p = 0.2). Values are mean ± s.e.m., t-test. D , E , distribution of Wake, NREM and REM in the two hours preceding and following each light transition. Light and dark hours are shaded in yellow and grey, respectively (see for comprehensive statistics). F , pairwise comparison in the content of Wake, NREM and REM between the hour preceding and each of the two hours following the light to dark transition. Control group: Wake -1 : 33.17 % ± 2.98 %, Wake 1 : 80.26 % ± 3.49 %, p < 0.0001, Wake 2 : 72.61 % ± 7.76 %, p = 0.001; NREM -1 : 60.08 % ± 2.65 %, NREM 1 : 18.39 % ± 3.29 %, p = 0.0001, NREM 2 : 25.17 % ± 7.04 %, p = 0.0015; REM -1 : 6.75 % ± 0.52 %, REM 1 : 1.35 % ± 0.45 % p = 0.0004, REM 2 : 2.18% ± 0.85 % p = 0.007. Ablated group: Wake -1 36.57 % ± 5.34 %, Wake 1 : 56.67 % ± 3.49 %, p = 0.093, Wake 2 : 75.23 % ± 7.24 %, p = 0.008; NREM -1 56.35 % ± 4.73 %, NREM 1 : 38.19 % ± 7.68 %, p = 0.093, NREM 2 : 22.36 % ± 6.64 %, p = 0.0081; REM -1 : 7.08 % ± 0.78 %, REM 1 : 5.10 % ± 1.16 %, p = 0.296, REM 2 : 2.41 % ± 0.90 %, p = 0.031. Values are mean ± s.e.m., t-test except Control REM -1 versus REM 2 , Ablated REM -1 versus REM 1 and REM 2 Wilcoxon test. G , pairwise comparison in the content of Wake, NREM and REM between the hour preceding and each of the two hours following the dark to light transition. Control group: Wake -1 : 94.77 % ± 3.48 %, Wake 1 : 63.47 % ± 9.42 %, p = 0.015, Wake 2 : 36.11 % ± 9.72 %, p = 0.015; NREM -1 : 5.22 % ± 3.48 %, NREM 1 : 34.87 % ± 8.82 % p = 0.015, NREM 2 : 57.51 % ± 8.86 % p = 0.015; REM -1 : 0.00 % ± 0.00 %, REM 1 : 1.66 % ± 0.64 %, p = 0.125, REM 2 : 6.37 % ± 1.09 %, p = 0.015. Ablated group: Wake -1 79.18 % ± 7.51 %, Wake 1 : 82.47 % ± 7.80 %, p = 0.812, Wake 2 : 39.37 % ± 8.09 %, p = 0.017; NREM -1 20.50 % ± 7.34 %, NREM 1 : 17.25 % ± 7.65 %, p = 0.848, NREM 2 : 56.31 % ± 7.22 %, p = 0.021; REM -1 : 0.31 % ± 0.21 %, REM 1 : 0.27 % ± 0.20 %, p > 0.999, REM 2 : 4.31 % ± 1.34 %, p = 0.0313. Values are mean ± s.e.m., Wilcoxon test except Ablated Wake -1 versus Wake 2 and NREM -1 versus NREM 2 t-test. H , fold change in distance travelled in the light phase (12 hours). Total distance in the dark phase (12 hours) was set at 1. Control group: 1.0 ± 0.14 (dark) versus 0.77 ± 0.26 (light); Ablated group: 1.0 ± 0.17 (dark) versus 0.52 ± 0.82 (light). I , Example trajectories for one control and one ablated mouse in the hour preceding and following the light change. Oval: ROI used for automated tracking; yellow: light, grey: dark. Histograms report the fold change in distance travelled in the hour preceding and following the light change. For the light to dark transition distance in the light was set at 1: Control group 1.0 ± 0.21 (light) 5.59 ± 1.36 (dark), p = 0.0078; Ablated group 1.0 ± 0.17 (light) 2.80 ± 0.68 (dark), p = 0.044. J , For the dark to light transition distance in the dark was set at 1: Control group 1.0 ± 0.15 vs 0.64 ± 0.31, p = 0.148; Ablated group 1.0 ± 0.28 vs 0.92 ± 0.29, p = 0.468. Values are mean ± s.e.m., Wilcoxon test except for Ablated light to dark transition t-test. A summary of statistical tests is available in .

Journal: bioRxiv

Article Title: A role for thalamic projection GABAergic neurons in circadian responses to light

doi: 10.1101/2022.02.24.481804

Figure Lengend Snippet: Ablation of Sox14 + IGL/LGv neurons causes delayed vigilance state transitions at circadian light changes. A , B , spectrograms, EEG/EMG traces, and hypnograms over a one-hour period from a representative control mouse and an ablated mouse. C , over a 24-hour period control and Sox14 + IGL/LGv-ablated mice spend a similar percentage of time in Wake (48.24 % ± 1.96 % vs 48.22 % ± 1.71 %, p = 0.99), NREM (46.73 % ± 1.80 % vs 46.38 % ± 1.71 %, p = 0.89) and REM (5.03 % ± 0.20 % vs 5.39 % ± 0.17 %, p = 0.2). Values are mean ± s.e.m., t-test. D , E , distribution of Wake, NREM and REM in the two hours preceding and following each light transition. Light and dark hours are shaded in yellow and grey, respectively (see for comprehensive statistics). F , pairwise comparison in the content of Wake, NREM and REM between the hour preceding and each of the two hours following the light to dark transition. Control group: Wake -1 : 33.17 % ± 2.98 %, Wake 1 : 80.26 % ± 3.49 %, p < 0.0001, Wake 2 : 72.61 % ± 7.76 %, p = 0.001; NREM -1 : 60.08 % ± 2.65 %, NREM 1 : 18.39 % ± 3.29 %, p = 0.0001, NREM 2 : 25.17 % ± 7.04 %, p = 0.0015; REM -1 : 6.75 % ± 0.52 %, REM 1 : 1.35 % ± 0.45 % p = 0.0004, REM 2 : 2.18% ± 0.85 % p = 0.007. Ablated group: Wake -1 36.57 % ± 5.34 %, Wake 1 : 56.67 % ± 3.49 %, p = 0.093, Wake 2 : 75.23 % ± 7.24 %, p = 0.008; NREM -1 56.35 % ± 4.73 %, NREM 1 : 38.19 % ± 7.68 %, p = 0.093, NREM 2 : 22.36 % ± 6.64 %, p = 0.0081; REM -1 : 7.08 % ± 0.78 %, REM 1 : 5.10 % ± 1.16 %, p = 0.296, REM 2 : 2.41 % ± 0.90 %, p = 0.031. Values are mean ± s.e.m., t-test except Control REM -1 versus REM 2 , Ablated REM -1 versus REM 1 and REM 2 Wilcoxon test. G , pairwise comparison in the content of Wake, NREM and REM between the hour preceding and each of the two hours following the dark to light transition. Control group: Wake -1 : 94.77 % ± 3.48 %, Wake 1 : 63.47 % ± 9.42 %, p = 0.015, Wake 2 : 36.11 % ± 9.72 %, p = 0.015; NREM -1 : 5.22 % ± 3.48 %, NREM 1 : 34.87 % ± 8.82 % p = 0.015, NREM 2 : 57.51 % ± 8.86 % p = 0.015; REM -1 : 0.00 % ± 0.00 %, REM 1 : 1.66 % ± 0.64 %, p = 0.125, REM 2 : 6.37 % ± 1.09 %, p = 0.015. Ablated group: Wake -1 79.18 % ± 7.51 %, Wake 1 : 82.47 % ± 7.80 %, p = 0.812, Wake 2 : 39.37 % ± 8.09 %, p = 0.017; NREM -1 20.50 % ± 7.34 %, NREM 1 : 17.25 % ± 7.65 %, p = 0.848, NREM 2 : 56.31 % ± 7.22 %, p = 0.021; REM -1 : 0.31 % ± 0.21 %, REM 1 : 0.27 % ± 0.20 %, p > 0.999, REM 2 : 4.31 % ± 1.34 %, p = 0.0313. Values are mean ± s.e.m., Wilcoxon test except Ablated Wake -1 versus Wake 2 and NREM -1 versus NREM 2 t-test. H , fold change in distance travelled in the light phase (12 hours). Total distance in the dark phase (12 hours) was set at 1. Control group: 1.0 ± 0.14 (dark) versus 0.77 ± 0.26 (light); Ablated group: 1.0 ± 0.17 (dark) versus 0.52 ± 0.82 (light). I , Example trajectories for one control and one ablated mouse in the hour preceding and following the light change. Oval: ROI used for automated tracking; yellow: light, grey: dark. Histograms report the fold change in distance travelled in the hour preceding and following the light change. For the light to dark transition distance in the light was set at 1: Control group 1.0 ± 0.21 (light) 5.59 ± 1.36 (dark), p = 0.0078; Ablated group 1.0 ± 0.17 (light) 2.80 ± 0.68 (dark), p = 0.044. J , For the dark to light transition distance in the dark was set at 1: Control group 1.0 ± 0.15 vs 0.64 ± 0.31, p = 0.148; Ablated group 1.0 ± 0.28 vs 0.92 ± 0.29, p = 0.468. Values are mean ± s.e.m., Wilcoxon test except for Ablated light to dark transition t-test. A summary of statistical tests is available in .

Article Snippet: The EEG/EMG signals were sampled at 250 Hz, amplified 100× and low-pass filtered at 100 Hz using a two EEG channel, two EMG channel mouse pre-amplifier (Pinnacle Technology Inc).

Techniques:

Representative raw EMG data of two participants demonstrating the cortical silent period (cSP) waterfall plot collected before (Pre) and after (Post) a single session of 1 Hz rTMS delivered to the laryngeal motor cortex. Each plot shows all 30 trials from one participant for each group before and after rTMS. AdLD adductor laryngeal dystonia, EMG electromyography, MEP motor-evoked potential

Journal: Experimental Brain Research

Article Title: Effects of low-frequency repetitive transcranial magnetic stimulation in adductor laryngeal dystonia: a safety, feasibility, and pilot study

doi: 10.1007/s00221-021-06277-4

Figure Lengend Snippet: Representative raw EMG data of two participants demonstrating the cortical silent period (cSP) waterfall plot collected before (Pre) and after (Post) a single session of 1 Hz rTMS delivered to the laryngeal motor cortex. Each plot shows all 30 trials from one participant for each group before and after rTMS. AdLD adductor laryngeal dystonia, EMG electromyography, MEP motor-evoked potential

Article Snippet: The electrode wires were connected to a bipolar electromyography (EMG) pre-amplifier (Y03, Motion Lab Systems, Inc., LA, USA) with a gain of × 300.

Techniques: